Superior Protection against Malaria and Melanoma Metastases by a C-glycoside Analogue of the Natural Killer T Cell Ligand α -Galactosylceramide

Journal of Experimental Medicine

Volumn 198, Issue 11, 2003, Pages 1631-1641

  Schmieg, John ^a   Yang, Guangli ^b   Franck, Richard W ^b   Tsuji, Moriya ^a,c  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CITY UNIVERSITY OF NEW YORK   (United States)

^c ROCKEFELLER UNIVERSITY   (United States)

Author keywords

C galactosylceramide; IFN ; IL 12; NK cell; NKT cell

Indexed keywords

ALPHA C GALACTOSYLCERAMIDE; ALPHA GALACTOSYLCERAMIDE; CYTOKINE; GALACTOSYLCERAMIDE; GAMMA INTERFERON; GLYCOLIPID; GLYCOSIDE; INTERLEUKIN 12; INTERLEUKIN 4; LIGAND; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIMALARIAL ACTIVITY; ARTICLE; CELL ACTIVATION; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG ACTIVITY; DRUG POTENCY; FEMALE; HUMAN; IMMUNE RESPONSE; IN VIVO STUDY; MALARIA; MELANOMA; METASTASIS; METASTASIS INHIBITION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; TH1 CELL; TH2 CELL;

ANIMALS; BASE SEQUENCE; DNA PRIMERS; FEMALE; GALACTOSYLCERAMIDES; INTERFERON TYPE II; KILLER CELLS, NATURAL; LIGANDS; MALARIA; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED BALB C; NEOPLASM METASTASIS;

EID: 0345167831     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20031192     Document Type: Article

References (33)

1. Bendelac, A., M.N. Rivera, S.H. Park, and J.H. Roark. 1997. Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu. Rev. Immunol. 15:535-562.
2. Godfrey, D.I., K.J.L. Hammond, L.D. Poulton, M.J. Smyth, and A.G. Baxter. 2000. NKT cells: facts, functions and fallacies. Immunol. Today. 21:573-583.
3. Kawano, T., J. Cui, Y. Koezuka, I. Toura, Y. Kaneko, K. Motoki, H. Ueno, R. Nakagawa, H. Sato, E. Kondo, et al. 1997. CD1d-restricted and TCR-mediated activation of Vα14 NKT cells by glycosylceramides. Science. 278:1626-1629.
4. Wilson, M.T., A.K. Singh, and L. Van Kaer. 2002. Immunotherapy with ligands of natural killer T cells. Trends Mol. Med. 8:225-231.
5. Matsuda, J.L., O.V. Naidenko, L. Gapin, T. Nakayama, M. Taniguchi, C. Wang, Y. Koezuka, and M. Kronenberg. 2000. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J. Exp. Med. 192:741-753.
6. Carnaud, C., D. Lee, O. Donnars, S. Park, A. Beavis, Y. Koezuka, and A. Bendelac. 1999. Cutting edge: cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J. Immunol. 163:4647-4650.
7. Eberl, G., and H.R. MacDonald. 2000. Selective induction of NK cell proliferation and cytotoxicity by activated NKT cells. Eur. J. Immunol. 30:985-992.
8. Eberl, G., P. Brawand, and H.R. MacDonald. 2000. Selective bystander proliferation of memory CD4+ and CD8+ T cells upon NK T or T cell activation. J. Immunol. 165:4305-4311.
9. Kitamura, H., K. Iwakabe, T. Yahata, S. Nishimura, A. Ohata, Y. Ohmi, M. Sato, K. Takeda, K. Okumura, L. Van Kaer, et al. 1999. The natural killer T (NKT) cell ligand α-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells. J. Exp. Med. 189:1121-1128.
10. Tomura, M., W. Yu, H. Ahn, M. Yamashita, Y. Yang, S. Ono, T. Hamaoka, T. Kawano, M. Taniguchi, Y. Koezuka, and H. Fujiwara. 1999. A novel function of Vα14+ CD4+NKT cells: stimulation of IL-12 production by antigen-presenting cells in the innate immune system. J. Immunol. 163:93-101.
11. Yang, Y., M. Tomura, S. Ono, T. Hamaoka, and H. Fujiwara. 2000. Requirement for IFN-γ in IL-12 production induced by collaboration between Vα14+ NKT cells and antigen-presenting cells. Int. Immunol. 12:1669-1675.
12. Pal, E., T. Tabira, T. Kawano, M. Taniguchi, S. Miyake, and T. Yamamura. 2001. Costimulation-dependent modulation of experimental autoimmune encephalomyelitis by ligand stimulation of Vα14 NK T cells. J. Immunol. 166:662-668.
13. H2 bias of natural killer T cells. Nature. 413:531-534.
14. Bertozzi, C.R., and M.D. Bednarski. 1996. Synthesis of C-glycosides: stable mimics of O-glycosidic linkages. In Modern Methods in Carbohydrate Synthesis. S.H. Khan and R.A. O'Neill, editors. Harwood Academic Publishers, London, UK. 316-351.
15. Bertozzi, C.R., D.G. Cook, W.R. Kobertz, F. Gonzalez-Scarano, and M.D. Bednarski. 1992. Carbon-linked galactosphingolipid analogs bind specifically to HIV-1 gp120. J. Am. Chem. Soc. 114:10639-10641.
16. Bruna-Romero, O., J.C.R. Hafalla, G. Gonzalez-Aseguinolaza, G. Sano, M. Tsuji, and F. Zavala. 2001. Detection of malaria liver-stages in mice infected through the bite of a single Anopheles mosquito using a highly sensitive real-time PCR. Int. J. Parasitol. 31:1499-1502.
17. Fujii, S., K. Shimizu, M. Kronenberg, and R.M. Steinman. 2002. Prolonged IFN-γ-producing NKT response induced with α -galactosylceramide-loaded DCs. Nat. Immunol. 3:867-874.
18. Griffin, F.K., D.E. Paterson, P.V. Murphy, and R.J.K. Taylor. 2002. A new route to exo-glycals using the Ramberg-Backlund rearrangement. Eur. J. Org. 2002:1305-1323.
19. Yang, G., R.W. Franck, R. Bittman, P. Samadder, and G. Arthur. 2001. Synthesis and growth inhibitory properties of glucosamine-derived glycerolipids. Org. Lett. 3:197-200.
20. Yang G., R.W. Franck, H.S. Byun, R. Bittman, P. Samadder, and G. Arthur G. 1999. Convergent C-glycolipid synthesis via the Ramberg-Backlund reaction: active antiproliferative glycolipids. Org. Lett. 1:2149-2151.
21. De Jonghe, S., I. Lamote, K. Venkataraman, S.A. Boldin, U. Hillaert, J. Rozenski, C. Hendrix, R. Busson, D. De Keukeleire, S. Van Calenbergh, et al. 2002. Synthesis of homoceramides, novel ceramide analogues, and their lack of effect on the growth of hippocampal neurons. J. Org. Chem. 67:988-996.
22. Morita, M., K. Motoki, K. Akimoto, T. Natori, T. Sakai, E. Sawa, K. Yamaji, Y. Koezuka, E. Kobayashi, and H. Fukushima. 1995. Structure-activity relationship of alpha-galactosylceramides against B16-bearing mice. J. Med. Chem. 38:2176-2187.
23. Gonzalez-Aseguinolaza, G., C. de Oliveira, M. Tomaska, S. Hong, O. Bruna-Romero, T. Nakayama, M. Taniguchi, A. Bendelac, L. Van Kaer, Y. Koezuka, et al. 2000. α-Galactosylceramide-activated Vα14 natural killer T cells mediate protection against murine malaria. Proc. Natl. Acad. Sci. USA. 97:8461-8466.
24. Chen, Y., N.M. Chiu, M. Mandal, N. Wang, and C. Wang. 1997. Impaired NK1+ T cell development and early IL-4 production in CD1-deficient mice. Immunity. 6:459-467.
25. Cui, J., T. Shin, T. Kawano, H. Sato, E. Kondo, I. Toura, Y. Kaneko, H. Koseki, M. Kanno, and M. Taniguchi. 1997. Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors. Science. 278:1623-1626.
26. + T cells and natural killer cells is essential for the antimetastatic effect of α-galactosylceramide. Blood. 99:1259-1266.
27. Wilson, M.T., C. Johansson, D. Olivares-Villagomez, A.K. Singh, A.K. Stanic, C.R. Wang, S. Joyce, M.J. Wick, and L. Van Kaer. 2003. The response of natural killer T cells to glycolipid antigens is characterized by surface receptor down-modulation and expansion. Proc. Natl. Acad. Sci. USA. 100:10913-10918.
28. Chan, S.H., B. Perussia, J.W. Gupta, M. Kobayashi, M. Pospisil, H.A. Young, S.F. Wolf, D. Young, S.C. Clark, and G. Trinchieri. 1991. Induction of interferon γ production by natural killer stimulatory: characterization of the responder cells and synergy with other inducers. J. Exp. Med. 173:869-879.
29. Matsuda, J.L., L. Gapin, J.L. Baron, S. Sidobre, D.B. Stetson, M. Mohrs, R.M. Locksley, and M. Kronenberg. 2003. Mouse V alpha 14i natural killer T cells are resistant to cytokine polarization in vivo. Proc. Natl. Acad. Sci. USA. 100:8395-8400.
30. Sloan-Lancaster, J., and P.M. Allen. 1996. Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology. Annu. Rev. Immunol. 14:1-27.
31. Brossay, L., M. Chioda, N. Burdin, Y. Koezuka, G. Casorati, P. Dellabona, and M. Kronenberg. 1998. CD1d-mediated recognition of an α -galactosylceramide by natural killer T cells is highly conserved through mammalian evolution. J. Exp. Med. 188:1521-1528.
32. Giaccone, G., C.J.A. Punt, Y. Ando, R. Ruijter, N. Nishi, M. Peters, B.M.E. von Blomberg, R.J. Scheper, H.J.J. van der Vliet, A.J.M. van den Eertwegh, et al. 2002. A phase I study of the natural killer T-cell ligand α-galactosylceramide (KRN7000) in patients with solid tumors. Clin. Cancer Res. 8:3702-3709.
33. Okai, M., M. Nieda, A. Tazbirkova, D. Horley, A. Kikuchi, S. Durrant, T. Takahasi, A. Boyd, R. Abraham, H. Yagita, et al. 2002. Human peripheral blood Vα24+ Vβ11+ NKT cells expand following administration of α-galactosylceramide-pulsed dendritic cells. Vox Sang. 83:250-253.